BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vossen ARJV, van der Zee HH, Prens EP. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model. Front Immunol. 2018;9:2965. [PMID: 30619323 DOI: 10.3389/fimmu.2018.02965] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Garcovich S, Genovese G, Moltrasio C, Malvaso D, Marzano AV. PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa. Clin Dermatol 2021;39:240-7. [PMID: 34272017 DOI: 10.1016/j.clindermatol.2020.10.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gargallo-Benedicto A, Clemente-Tomás R, Pastor-Espuig M, Ballano-Ruiz A, Garzarán-Teijeiro A, Alias-Alegre E, Navarro-Casado MN. Bilateral Phlyctenular Keratoconjunctivitis in the Context of Hidradenitis Suppurativa: A Case Report and Literature Review. Ocul Immunol Inflamm 2020;:1-3. [PMID: 33226311 DOI: 10.1080/09273948.2020.1833223] [Reference Citation Analysis]
3 Frew JW, Piguet V. Ex Vivo Models and Interpretation of Mechanistic Studies in Hidradenitis Suppurativa. J Invest Dermatol 2020;140:1323-6. [PMID: 32571498 DOI: 10.1016/j.jid.2020.02.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Frew JW, Grand D, Navrazhina K, Krueger JG. Beyond antibodies: B cells in Hidradenitis Suppurativa: Bystanders, contributors or therapeutic targets? Exp Dermatol 2020;29:509-15. [PMID: 32145106 DOI: 10.1111/exd.14092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
5 Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K. Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study. Br J Dermatol 2021;184:133-40. [PMID: 32119111 DOI: 10.1111/bjd.18983] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 21.0] [Reference Citation Analysis]
6 Penno CA, Jäger P, Laguerre C, Hasler F, Hofmann A, Gass SK, Wettstein-Ling B, Schaefer DJ, Avrameas A, Raulf F, Wieczorek G, Lehmann JCU, Loesche C, Roth L, Röhn TA. Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4. J Invest Dermatol 2020;140:2421-2432.e10. [PMID: 32387270 DOI: 10.1016/j.jid.2020.04.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
7 Damiani G, Mahroum N, Pigatto PDM, Pacifico A, Malagoli P, Tiodorovic D, Conic RR, Amital H, Bragazzi NL, Watad A, Adawi M. The Safety and Impact of a Model of Intermittent, Time-Restricted Circadian Fasting ("Ramadan Fasting") on Hidradenitis Suppurativa: Insights from a Multicenter, Observational, Cross-Over, Pilot, Exploratory Study. Nutrients 2019;11:E1781. [PMID: 31374976 DOI: 10.3390/nu11081781] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
8 Hernández JL, Baldeón C, López-Sundh AE, Ocejo-Vinyals JG, Blanco R, González-López MA. Atherogenic index of plasma is associated with the severity of Hidradenitis Suppurativa: a case-control study. Lipids Health Dis 2020;19:200. [PMID: 32861241 DOI: 10.1186/s12944-020-01377-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zouboulis CC, Benhadou F, Byrd AS, Chandran NS, Giamarellos‐bourboulis EJ, Fabbrocini G, Frew JW, Fujita H, González‐lópez MA, Guillem P, Gulliver WPF, Hamzavi I, Hayran Y, Hórvath B, Hüe S, Hunger RE, Ingram JR, Jemec GB, Ju Q, Kimball AB, Kirby JS, Konstantinou MP, Lowes MA, Macleod AS, Martorell A, Marzano AV, Matusiak Ł, Nassif A, Nikiphorou E, Nikolakis G, Nogueira da Costa A, Okun MM, Orenstein LA, Pascual JC, Paus R, Perin B, Prens EP, Röhn TA, Szegedi A, Szepietowski JC, Tzellos T, Wang B, van der Zee HH. What causes hidradenitis suppurativa ?—15 years after. Exp Dermatol 2020;29:1154-70. [DOI: 10.1111/exd.14214] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
10 González-López MA, Vilanova I, Ocejo-Viñals G, Arlegui R, Navarro I, Guiral S, Mata C, Pérez-Paredes MG, Portilla V, Corrales A, González-Vela MC, González-Gay MA, Blanco R, Hernández JL. Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa. Arch Dermatol Res 2020;312:595-600. [PMID: 31786710 DOI: 10.1007/s00403-019-02018-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 González-López MA, Ocejo-Viñals JG, Mata C, Díaz D, Guiral S, Portilla V, Corrales A, González-Vela MC, González-Gay MA, Blanco R, Hernández JL. Evaluation of serum omentin-1 and apelin concentrations in patients with hidradenitis suppurativa. Postepy Dermatol Alergol 2021;38:450-4. [PMID: 34377127 DOI: 10.5114/ada.2021.107932] [Reference Citation Analysis]
12 Navrazhina K, Frew JW, Gilleaudeau P, Sullivan-Whalen M, Garcet S, Krueger JG. Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa. J Allergy Clin Immunol 2021;147:2213-24. [PMID: 33548397 DOI: 10.1016/j.jaci.2020.12.651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
13 Gotesman RD, Choi C, Alavi A. Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review and meta-analysis. Int J Dermatol 2021. [PMID: 34075575 DOI: 10.1111/ijd.15671] [Reference Citation Analysis]
14 Navrazhina K, Garcet S, Zheng X, Hur HB, Frew JW, Krueger JG. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression. J Allergy Clin Immunol 2021:S0091-6749(21)00832-0. [PMID: 34081946 DOI: 10.1016/j.jaci.2021.05.027] [Reference Citation Analysis]
15 Bodkin AJ, Criswell SL. Hidradenitis suppurativa lesions are associated with decreased collagen, decreased elastin, and increased neovascularization. J Histotechnol 2021;44:80-9. [PMID: 33757414 DOI: 10.1080/01478885.2020.1861924] [Reference Citation Analysis]
16 Grand D, Navrazhina K, Frew JW. Integrating complement into the molecular pathogenesis of Hidradenitis Suppurativa. Exp Dermatol 2020;29:86-92. [PMID: 31688984 DOI: 10.1111/exd.14056] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
17 Del Duca E, Morelli P, Bennardo L, Di Raimondo C, Nisticò SP. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa. Int J Mol Sci 2020;21:E8436. [PMID: 33182701 DOI: 10.3390/ijms21228436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
18 Vossen ARJV, van Straalen KR, Swagemakers SMA, de Klein JEMM, Stubbs AP, Venter DJ, van der Zee HH, van der Spek PJ, Prens EP. A novel nicastrin mutation in a three-generation Dutch family with hidradenitis suppurativa: a search for functional significance. J Eur Acad Dermatol Venereol 2020;34:2353-61. [PMID: 32078194 DOI: 10.1111/jdv.16310] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
19 Zhou P, Liu J, Xu T, Guo Y, Han Y, He Y, Lin L, Xiao X. Mutations in γ-secretase subunit-encoding PSENEN gene alone may not be sufficient for the development of acne inversa. J Dermatol Sci 2021:S0923-1811(21)00143-2. [PMID: 34330582 DOI: 10.1016/j.jdermsci.2021.06.007] [Reference Citation Analysis]
20 Cartron A, Driscoll MS. Comorbidities of hidradenitis suppurativa: A review of the literature. Int J Womens Dermatol 2019;5:330-4. [PMID: 31909152 DOI: 10.1016/j.ijwd.2019.06.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
21 Frew JW, Navrazhina K, Marohn M, Lu PC, Krueger JG. Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa. Exp Dermatol 2019;28:886-91. [PMID: 31140657 DOI: 10.1111/exd.13978] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
22 Fletcher JM, Moran B, Petrasca A, Smith CM. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa. Clin Exp Immunol 2020;201:121-34. [PMID: 32379344 DOI: 10.1111/cei.13449] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
23 Zouboulis CC, Nogueira da Costa A, Makrantonaki E, Hou XX, Almansouri D, Dudley JT, Edwards H, Readhead B, Balthasar O, Jemec GBE, Bonitsis NG, Nikolakis G, Trebing D, Zouboulis KC, Hossini AM. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2020;34:846-61. [PMID: 31838778 DOI: 10.1111/jdv.16147] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]
24 Vossen ARJV, van Straalen KR, Florencia EF, Prens EP. Lesional Inflammatory Profile in Hidradenitis Suppurativa Is Not Solely Driven by IL-1. J Invest Dermatol 2020;140:1463-1466.e2. [PMID: 32081612 DOI: 10.1016/j.jid.2020.01.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
25 González‐lópez MA, Ocejo‐viñals JG, Mata C, Vilanova I, Guiral S, Portilla V, Blanco R, Hernández JL. Association of retinol binding protein4 (RBP4) and ghrelin plasma levels with insulin resistance and disease severity in non‐diabetic patients with hidradenitis suppurativa. Exp Dermatol 2020;29:828-32. [DOI: 10.1111/exd.14132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 van Straalen KR, Tzellos T, Guillem P, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Jemec GBE, Katoulis AC, Koenig A, Lazaridou E, Marzano AV, Matusiak Ł, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Romaní J, Saunte DM, Skroza N, Stergianou D, Szepietowski J, Trigoni A, Vilarrasa E, van der Zee HH. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study. J Am Acad Dermatol 2021;85:369-78. [PMID: 33484766 DOI: 10.1016/j.jaad.2020.12.089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
27 Ardon CB, Wang C, Prens EP, van Straalen KR. Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches. Br J Dermatol 2021;184:343-5. [PMID: 32767746 DOI: 10.1111/bjd.19462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Frew JW. Commentary: Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model. Front Immunol 2019;10:302. [PMID: 30858850 DOI: 10.3389/fimmu.2019.00302] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
29 Frew JW, Navrazhina K. No evidence that impaired Notch signalling differentiates hidradenitis suppurativa from other inflammatory skin diseases. Br J Dermatol 2020;182:1042-3. [PMID: 31594026 DOI: 10.1111/bjd.18593] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
30 Sayed CJ, Hsiao JL, Okun MM; Hidradenitis Suppurativa Foundation Women's Health Subcommittee. Clinical Epidemiology and Management of Hidradenitis Suppurativa. Obstet Gynecol 2021;137:731-46. [PMID: 33706337 DOI: 10.1097/AOG.0000000000004321] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Dunstan RW, Salte KM, Todorović V, Lowe M, Wetter JB, Harms PW, Burney RE, Scott VE, Smith KM, Rosenblum MD, Gudjonsson JE, Honore P. Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention. Exp Dermatol 2021;30:820-30. [PMID: 33377546 DOI: 10.1111/exd.14273] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
32 Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa. Journal of the American Academy of Dermatology 2020;82:1045-58. [DOI: 10.1016/j.jaad.2019.08.090] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 35.0] [Reference Citation Analysis]
33 Frew JW. Hidradenitis suppurativa is an autoinflammatory keratinization disease: A review of the clinical, histologic, and molecular evidence. JAAD Int 2020;1:62-72. [PMID: 34409324 DOI: 10.1016/j.jdin.2020.05.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
34 Caposiena Caro RD, Cannizzaro MV, Tartaglia C, Bianchi L. Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab. Clin Exp Dermatol 2020;45:438-44. [DOI: 10.1111/ced.14127] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
35 van Straalen KR. Chronic Pain in Hidradenitis Suppurativa Explained Through the Process of Central Sensitization. JAMA Dermatol 2020;156:615-6. [PMID: 32267476 DOI: 10.1001/jamadermatol.2020.0225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
36 Collier EK, Parvataneni RK, Lowes MA, Naik HB, Okun M, Shi VY, Hsiao JL. Diagnosis and management of hidradenitis suppurativa in women. Am J Obstet Gynecol 2021;224:54-61. [PMID: 32980357 DOI: 10.1016/j.ajog.2020.09.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Basal Y, Oommen J, Faraj U, Acho R, Aravapally A. Facklamia hominis in hidradenitis suppurativa. JAAD Case Rep 2021;11:20-2. [PMID: 33898677 DOI: 10.1016/j.jdcr.2021.03.017] [Reference Citation Analysis]
38 Gutfilen-Schlesinger G, Lopes de Souza SA, Gutfilen B. Should We Scan Hidradenitis Suppurativa Patients? A Systematic Review of Radiologic Findings. Adv Skin Wound Care 2021;34:1-10. [PMID: 34125731 DOI: 10.1097/01.ASW.0000753196.64470.6a] [Reference Citation Analysis]
39 Narla S, Azzam M, Townsend S, Vellaichamy G, Marzano AV, Alavi A, Lowes MA, Hamzavi IH. Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils. Br J Dermatol 2021;184:1004-13. [PMID: 32893875 DOI: 10.1111/bjd.19538] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
40 Ferri G, Tricarico PM, Vincelli I, Gratton R, Ottaviani G, Boniotto M, Zupin L, Crovella S. Photobiomodulation therapy is able to decrease IL1B gene expression in an in vitro cellular model of hidradenitis suppurativa. Lasers Med Sci 2020;35:1003-5. [PMID: 31444612 DOI: 10.1007/s10103-019-02868-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Assan F, Gottlieb J, Tubach F, Lebbah S, Guigue N, Hickman G, Pape E, Madrange M, Delaporte E, Sendid B, Aubin F, Derouin F, Bretagne S, Richette P, Smahi A, Sbidian E, Bachelez H. Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa. Journal of Allergy and Clinical Immunology 2020;146:452-455.e5. [DOI: 10.1016/j.jaci.2020.01.045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
42 Altman SR, Criswell SL. Dynamic Leukocyte Populations Are Associated With Early- and Late-stage Lesions in Hidradenitis Suppurativa. J Histochem Cytochem 2021;69:191-201. [PMID: 33238789 DOI: 10.1369/0022155420978535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol 2019; 11(4): 391-401 [PMID: 31114643 DOI: 10.4254/wjh.v11.i4.391] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
44 Aarts P, Dudink K, Vossen ARJV, van Straalen KR, Ardon CB, Prens EP, van der Zee HH. Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa. Drugs 2021;81:1397-410. [PMID: 34283386 DOI: 10.1007/s40265-021-01566-2] [Reference Citation Analysis]
45 Bettoli V, Schettini N, Libanore M, Scuderi V, Zedde P, Forconi R, Pacetti L, Ceccherini I, Gattorno M, Poggioli G, Corazza M. The Association among Pyoderma Gangrenosum, Ulcerative Colitis, and Hidradenitis Suppurativa and the Syndromic Hidradenitis Suppurativa Network: A Case Report. Skin Appendage Disord 2021;7:227-30. [PMID: 34055914 DOI: 10.1159/000513639] [Reference Citation Analysis]
46 Caposiena Caro RD, Solivetti FM, Candi E, Bianchi L. Clinical and Power-Doppler ultrasound features related with persistence of fistulous tracts under treatment with adalimumab in hidradenitis suppurativa: 4 years of follow-up. Dermatol Ther 2021;34:e14804. [PMID: 33486868 DOI: 10.1111/dth.14804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Nguyen T, Damiani G, Orenstein L, Hamzavi I, Jemec G. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol 2021;35:50-61. [DOI: 10.1111/jdv.16677] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 23.0] [Reference Citation Analysis]
48 Machado MO, Kang NC, Tai F, Sambhi RDS, Berk M, Carvalho AF, Chada LP, Merola JF, Piguet V, Alavi A. Measuring fatigue: a meta-review. Int J Dermatol 2021;60:1053-69. [PMID: 33301180 DOI: 10.1111/ijd.15341] [Reference Citation Analysis]
49 Langan EA, Recke A, Bokor-Billmann T, Billmann F, Kahle BK, Zillikens D. The Role of the Cutaneous Microbiome in Hidradenitis Suppurativa-Light at the End of the Microbiological Tunnel. Int J Mol Sci 2020;21:E1205. [PMID: 32054085 DOI: 10.3390/ijms21041205] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
50 Gratton R, Tricarico PM, d'Adamo AP, Bianco AM, Moura R, Agrelli A, Brandão L, Zupin L, Crovella S. Notch Signaling Regulation in Autoinflammatory Diseases. Int J Mol Sci 2020;21:E8847. [PMID: 33238371 DOI: 10.3390/ijms21228847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ghias MH, Hyde MJ, Tomalin LE, Morgan BP, Alavi A, Lowes MA, Piguet V. Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa. J Invest Dermatol 2020;140:531-536.e1. [PMID: 31870626 DOI: 10.1016/j.jid.2019.09.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
52 Papa R, Picco P, Gattorno M. The expanding pathways of autoinflammation: a lesson from the first 100 genes related to autoinflammatory manifestations. Adv Protein Chem Struct Biol 2020;120:1-44. [PMID: 32085880 DOI: 10.1016/bs.apcsb.2019.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
53 Yang JH, Cho SI, Kim DH, Yoon JY, Moon J, Kim JW, Choi S, Suh DH. Pilot study of fractional microneedling radiofrequency for hidradenitis suppurativa assessed by clinical response and histology. Clin Exp Dermatol 2021. [PMID: 34431555 DOI: 10.1111/ced.14905] [Reference Citation Analysis]